Baxter Recommended on Weakness and 4 Stock Analyses Buzzing Now

Stratasys Inc. (NASDAQ:SSYS): Current Price: $90.14

According to Piper Jaffray’s channel checks, Stratasys will report Q4 results that are slightly higher than consensus estimates. Furthermore, Piper is convinced that the company is in the position for a solid 2013, and the firm decided to raise its price target for shares as it keeps its Overweight rating on the stock.

Capture

Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Click here for our fresh Feature Stock Pick now!

Baxter International Inc. (NYSE:BAX): Current Price: $66.50

RBC Capital recommends purchasing Baxter’s shares on any weakness after the company’s Q4 results and guidance. The firm believes that the company’s 2013 EPS guidance will be well below the consensus estimate, but the firm is not convinced that this should be a surprise considering its Gambro acquisition along with the changes regarding corporate bond rates. The firm keeps its Outperform rating and a $70 price target on the stock.

Capture

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

Deckers Outdoor Corp. (NASDAQ:DECK): Current Price: $37.35

The company’s expectations have been lowered by Canaccord as a result of reduced UGG wholesale sales estimates. Shares keep a Hold rating and lowers its price target to $35 price target, down from $37.

Capture

 

Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Click here for our fresh Feature Stock Pick now!

Xerox Corp. (NYSE:XRX): Current Price: $7.58

Brean Capital is convinced that Xerox continues to be undervalued due to positive implications for its use of its free cash flow. The firm believes that there are options for debt reduction and share repurchase, which would be positive for the equity. The firm gives the shares a Buy rating and a $8.00 price target.

Capture

MAKO Surgical Corp. (NASDAQ:MAKO): Current Price: $11.23

William Blair believes that Zimmer’s (NYSE:ZMH) iASSIST Knee is currently a threat to MAKO Surgical’s partial knee business. The firm thinks that it will take a number of years for Zimmer to develop the clinical data that is needed for surgeons to feel comfortable using the product. William Blair believes that MAKO will begin to start meeting or exceeding consensus expectations, and the firm reiterates its Outperform rating on the stock.

Capture

Don’t Miss: Is Apple Scared of Amazon’s Music Moves?